The autoinhibitory function of D1 domain of FGFR1 goes beyond the inhibition of ligand binding

Published on Aug 1, 2017in The International Journal of Biochemistry & Cell Biology3.673
· DOI :10.1016/J.BIOCEL.2017.06.015
Lukasz Opalinski3
Estimated H-index: 3
(UWr: University of Wrocław),
Martyna Szczepara3
Estimated H-index: 3
(UWr: University of Wrocław)
+ 2 AuthorsJacek Otlewski44
Estimated H-index: 44
(UWr: University of Wrocław)
Sources
Abstract
Abstract Fibroblast growth factors (FGFs) and their plasma membrane-localized receptors (FGFRs) transduce signals that regulate developmental processes and metabolism. In numerous cancer types genetic aberrations of FGFR1 lead to its uncontrolled activation. To circumvent the unrestrained signal transduction, several intramolecular inhibitory mechanisms within FGFR1 have evolved. In vitro experiments with receptor truncation have demonstrated that the N-terminal D1 domain of FGFR1 negatively regulates ligand binding to the receptor. Here, we show that D1-specific monovalent antibody fragments can activate FGFR1 and its downstream signaling cascades in the absence of ligand. These data suggest that the D1 domain of FGFR1 may play autoinhibitory role not only by controlling ligand binding, but also by regulating the overall conformation of FGFR1, keeping it in a state that disfavors autoactivation in the absence of its cognate growth factor.
📖 Papers frequently viewed together
201238.64Cell
9 Authors (Chi-Chuan Lin, ..., John E. Ladbury)
106 Citations
20174.37Cells
71 Citations
373 Citations
References16
Newest
#1Aleksandra Sokolowska-Wedzina (UWr: University of Wrocław)H-Index: 7
#2Grzegorz ChodaczekH-Index: 10
Last. Jacek Otlewski (UWr: University of Wrocław)H-Index: 44
view all 6 authors...
Targeted delivery of anti-cancer drugs using antibodies specific for tumor-associated antigens represents one of the most important approaches in current immuno-oncology research. Fibroblast growth factor receptor 1 (FGFR1) has been demonstrated to be a high-frequency targetable oncogene specific for smoking-associated lung cancers, present in over 20% of lung squamous cell carcinoma cases. This report describes the generation of a potent, fully human antibody fragment in scFv-Fc format efficien...
24 CitationsSource
#1Huaibin Chen (NYU: New York University)H-Index: 13
#2William M. Marsiglia (NYU: New York University)H-Index: 6
Last. Moosa Mohammadi (NYU: New York University)H-Index: 85
view all 11 authors...
Many growth factors and hormones instruct cells to act in particular ways – for example, to divide, specialize or migrate – by binding to proteins called receptor tyrosine kinases on the surface of the cell. Receptor tyrosine kinases comprise a region that binds to the signaling molecules outside the cell (the receptor domain) and a region that interacts with and modifies other proteins within the cell (the kinase domain). When a growth factor or hormone binds to the receptor domain, the recepto...
23 CitationsSource
#1Teresa Helsten (UCSD: University of California, San Diego)H-Index: 15
Last. Razelle Kurzrock (UCSD: University of California, San Diego)H-Index: 133
view all 6 authors...
Purpose: Molecular profiling may have prognostic and predictive value, and is increasingly used in the clinical setting. There are more than a dozen fibroblast growth factor receptor (FGFR) inhibitors in development. Optimal therapeutic application of FGFR inhibitors requires knowledge of the rates and types of FGFR aberrations in a variety of cancer types. Experimental Design: We analyzed frequencies of FGFR aberrations in 4853 solid tumors that were, on physician request, tested in a Clinical ...
274 CitationsSource
#1Edward P. Carter (QMUL: Queen Mary University of London)H-Index: 6
#2Abbie E. Fearon (QMUL: Queen Mary University of London)H-Index: 4
Last. Richard Grose (QMUL: Queen Mary University of London)H-Index: 33
view all 3 authors...
Since its discovery 40 years ago, fibroblast growth factor (FGF) receptor (FGFR) signalling has been found to regulate fundamental cellular behaviours in a wide range of cell types. FGFRs regulate development, homeostasis, and repair and are implicated in many disorders and diseases; and indeed, there is extensive potential for severe consequences, be they developmental, homeostatic, or oncogenic, should FGF–FGFR signalling go awry, so careful control of the pathway is critically important. In t...
95 CitationsSource
#1Aleksandra Sokolowska-Wedzina (UWr: University of Wrocław)H-Index: 7
#2Aleksandra Borek (UWr: University of Wrocław)H-Index: 3
Last. Jacek Otlewski (UWr: University of Wrocław)H-Index: 44
view all 6 authors...
Abstract The family of fibroblast growth factor receptors (FGFRs) plays an important role in cell growth, survival, differentiation and angiogenesis. The three immunoglobulin-like extracellular domains of FGFR (D1, D2, and D3) are critical for ligand binding and specificity towards fibroblast growth factor and heparan sulfate. Fibroblast growth factor receptors are overexpressed in a wide variety of tumors, such as breast, bladder, and prostate cancer, and therefore they are attractive targets f...
20 CitationsSource
#1Stacey J. Coleman (QMUL: Queen Mary University of London)H-Index: 5
#2Charo Bruce (QMUL: Queen Mary University of London)H-Index: 1
Last. Richard Grose (QMUL: Queen Mary University of London)H-Index: 33
view all 5 authors...
FGFR (fibroblast growth factor receptor) signalling plays critical roles in embryogensis, adult physiology, tissue repair and many pathologies. Of particular interest over recent years, it has been implicated in a wide range of cancers, and concerted efforts are underway to target different aspects of FGFR signalling networks. A major focus has been identifying the canonical downstream signalling pathways in cancer cells, and these are now relatively well understood. In the present review, we fo...
37 CitationsSource
#1Junming Yie (Amgen)H-Index: 19
#2Wei Wang (Amgen)H-Index: 10
Last. Minghan Wang (Amgen)H-Index: 21
view all 13 authors...
The endocrine fibroblast growth factor 21 (FGF21) requires both fibroblast growth factor receptor (FGFR) and β-Klotho for signaling. In this study, we sought to understand the inter-molecular physical interactions in the FGF21/FGFR/β-Klotho complex by deleting key regions in FGFR1c or FGF21. Deletion of the D1 and the D1-D2 linker (the D1/linker region) from FGFR1c led to β-Klotho-independent receptor activation by FGF21, suggesting that there may be a direct interaction between FGF21 and the D1...
68 CitationsSource
#1Juliya Kalinina (NYU: New York University)H-Index: 11
#2Kaushik DuttaH-Index: 25
Last. Moosa Mohammadi (NYU: New York University)H-Index: 85
view all 8 authors...
Uncontrolled fibroblast growth factor (FGF) signaling can lead to human malignancies necessitating multiple layers of self-regulatory control mechanisms. Fibroblast growth factor receptor (FGFR) autoinhibition mediated by the alternatively spliced immunoglobulin (Ig) domain 1 (D1) and the acid box (AB)-containing linker between D1 and Ig domain 2 (D2) serves as the first line of defense to minimize inadvertent FGF signaling. In this report, nuclear magnetic resonance and surface plasmon resonanc...
53 CitationsSource
#1Jørgen Wesche (Oslo University Hospital)H-Index: 24
#2Kaisa Haglund (Oslo University Hospital)H-Index: 23
Last. Ellen Margrethe Haugsten (Oslo University Hospital)H-Index: 2
view all 3 authors...
FGFs (fibroblast growth factors) and their receptors (FGFRs) play essential roles in tightly regulating cell proliferation, survival, migration and differentiation during development and adult life. Deregulation of FGFR signalling, on the other hand, has been associated with many developmental syndromes, and with human cancer. In cancer, FGFRs have been found to become overactivated by several mechanisms, including gene amplification, chromosomal translocation and mutations. FGFR alterations are...
406 CitationsSource
#1Darren C. Tomlinson (St James's University Hospital)H-Index: 29
#2Margaret A. Knowles (St James's University Hospital)H-Index: 83
Fibroblast growth factor receptors (FGFRs) play key roles in proliferation, differentiation, and tumorigenesis. Previously, we demonstrated that FGFR1 expression is increased in urothelial carcinoma cell lines and tumors, which promotes proliferation and survival via activation of the mitogen-activated protein kinase (MAPK) pathway. Here we examined splice variants of FGFR1 in both urothelial carcinoma cell lines and tumors. Two known FGFR1 IIIc splice variants (FGFR1α and FGFR1β) were expressed...
39 CitationsSource
Cited By4
Newest
#1Marta Poźniak (UWr: University of Wrocław)
#2Natalia Porębska (UWr: University of Wrocław)H-Index: 3
Last. Łukasz Opaliński (UWr: University of Wrocław)H-Index: 7
view all 10 authors...
BACKGROUND Antibody drug conjugates (ADCs) represent one of the most promising approaches in the current immuno-oncology research. The precise delivery of cytotoxic drugs to the cancer cells using ADCs specific for tumor-associated antigens enables sparing the healthy cells and thereby reduces unwanted side effects. Overexpression of fibroblast growth factor receptor 1 (FGFR1) has been demonstrated in numerous tumors and thereby constitutes a convenient molecular target for selective cancer trea...
1 CitationsSource
#1Norihiko SasakiH-Index: 14
#2Fujiya GomiH-Index: 4
Last. Toshiyuki IshiwataH-Index: 42
view all 11 authors...
Fibroblast growth factor receptor 4 (FGFR4), one of four tyrosine kinase receptors for FGFs, is involved in diverse cellular processes. Activation of FGF19/FGFR4 signaling is closely associated with cancer development and progression. In this study, we examined the expression and roles of FGF19/FGFR4 signaling in human pancreatic ductal adenocarcinoma (PDAC). In human PDAC cases, FGFR4 expression positively correlated with larger primary tumors and more advanced stages. Among eight PDAC cell lin...
1 CitationsSource
#1Marta Pozniak (UWr: University of Wrocław)H-Index: 1
#2Aleksandra Sokolowska-Wedzina (UWr: University of Wrocław)H-Index: 7
Last. Lukasz Opalinski (UWr: University of Wrocław)H-Index: 3
view all 10 authors...
Fibroblast growth factor receptor 1 (FGFR1) transmits signals through the plasma membrane regulating essential cellular processes like division, motility, metabolism and death. Overexpression of FGFR1 is observed in numerous tumors and thus constitutes an attractive molecular target for selective cancer treatment. Targeted anti-cancer therapies aim for the precise delivery of drugs into cancer cells, sparing the healthy ones and thus limiting unwanted side effects. One of the key steps in target...
3 CitationsSource
#1Marta Latko (UWr: University of Wrocław)H-Index: 3
#2Aleksandra Czyrek (UWr: University of Wrocław)H-Index: 6
Last. Łukasz Opaliński (UWr: University of Wrocław)H-Index: 7
view all 7 authors...
Fibroblast growth factors (FGFs) and their receptors (FGFRs) constitute signaling circuits that transmit signals across the plasma membrane, regulating pivotal cellular processes like differentiation, migration, proliferation, and apoptosis. The malfunction of FGFs/FGFRs signaling axis is observed in numerous developmental and metabolic disorders, and in various tumors. The large diversity of FGFs/FGFRs functions is attributed to a great complexity in the regulation of FGFs/FGFRs-dependent signa...
26 CitationsSource